Table 1—

Baseline characteristics of patients completing the protocol

ROSIPIOP value
Gender (male/female)27/3335/320.42
Age (years)57.1 ± 12.157.8 ± 11.00.73
Weight (kg)103.2 ± 24.8101.4 ± 24.20.67
BMI (kg/m2)35.6 ± 7.435.2 ± 7.40.76
HbAlc7.9 ± 1.98.0 ± 1.70.58
Cholesterol (mg/dl)190.7 ± 44.1196.9 ± 44.50.43
HDL cholesterol (mg/dl)45.3 ± 15.244.7 ± 15.60.83
LDL cholesterol (mg/dl)105.9 ± 29.7116.2 ± 38.00.10
Triglyercide (mg/dl)236.0 ± 222.0181.0 ± 110.10.19
HMG-CoA reductase inhibitor use35 (58)40 (60)0.88
Metformin use16 (27)22 (33)0.45
Insulin use25 (42)39 (58)0.06
Sulfa use40 (67)41 (61)0.52
  • Data are means ± SD or n (%).